company

ENDOMED AS

1081 OSLO

Return on Equity
57,05 %
Current Ratio
1,69
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue24 940 000
Net Income2 669 000
Total Assets11 393 000
Total Equity4 678 000
Income (NOK)2022
Revenue24 940 000
Expenditure21 378 000
Operating Profit3 561 000
Financial Income97 000
Financial Costs232 000
Financial Balance−135 000
Earnings Before Tax3 426 000
Tax756 000
Net Income2 669 000
Balance (NOK)2022
Total Fixed Assets48 000
Total Current Assets11 344 000
Total Assets11 393 000
Total Retained Equity3 428 000
Total Equity4 678 000
Total Long-Term Debt0
Total Current Debt6 715 000
Total Equity and Debt11 393 000
Cash flow (NOK)2022
Sales Income24 940 000
Other Income0
Revenue24 940 000
Cost of Goods Sold15 161 000
Salary Costs2 841 000
Depreciation0
Impairment0
Expenditure21 378 000
Operating Profit3 561 000
Financial Income97 000
Financial Costs232 000
Financial Balance−135 000
Dividends0
Net Income2 669 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets48 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets48 000
Stock3 200 000
Total Investments0
Cash, Bank5 120 000
Total Current Assets11 344 000
Total Assets11 393 000
Total Equity4 678 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 550 000
Unpaid Taxes1 147 000
Dividends0
Other Current Debt4 019 000
Total Current Debt6 715 000
Total Equity and Debt11 393 000
Financial indicators2022
Return on Equity57,05 %
Debt-to-Equity Ratio0
Operating Profit Margin14,28 %
Current Ratio1,69
Quick Ratio3,23
Equity Ratio0,41
Gross Profit Margin39,21 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English